Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CADET-UD adjunctive candesartan trial for major depressive disorder
ACTRN12620001095954Phase 3Recruiting
- Sponsor
- Deakin University
- Start
- Oct 2021
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in major depressive disorder (MDD) comparing Adjunctive candesartan with Adjunctive placebo (2 arms). Primary endpoint: Change in severity of mood symptoms measured by Montgomery-Åsberg Depression Rating Scale (MADRS). Started Oct 2021; status: recruiting.
02
Drugs
candesartan
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ACTRN12620001095954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001095954.